Meitar represented the baby food importer Heinz – Remedia and the former CEO of the company in criminal proceedings involving charges of involuntary manslaughter arising from allegations of tainted baby formula. After five years of litigation, the court acquitted the former CEO of all charges relating to the baby formula. The State has filed an appeal of the acquittal, which is still pending.
Our firm represented Barclays Capital Inc. and Citigroup Global Markets Inc. in the $1.4 billion global notes offering by Israel Electric Corporation.
In July 2013, an Israeli court ruled in favor of the Bronner brothers, represented by Meitar, in a complex inheritance dispute with their siblings, which is a part of a broader dispute involving a worldwide diamond and real-estate business.
Our firm represented J.P Morgan Securities, Merrill Lynch and several other underwriters in the $127 million initial public offering by Wix.com, including both primary and secondary shares, on NASDAQ.
Meitar represented SanDisk in the defense of a motion to certify a class action relating to media players, leading to the dismissal of the action.
Meitar represented TASE-listed Evogene, a plant genomics company, in its $73.8 million initial public offering on the NYSE.
Meitar represented the directors and officers of Leadcom Integrated Solutions in opposing a motion to certify a NIS 115 million class action relating to an allegedly misleading prospectus. The court dismissed the motion, finding that the issue is not suitable for adjudication as a class action.
